KMTSKestra Medical Technologies, Ltd.

$28.78+24% 1Y

Is the price fair?

What KMTS's price assumes

Kestra Medical Technologies, Ltd. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 16.1× revenue.

16.1

Price / sales · no P/E: the last twelve months did not end in a profit

Price / book
7.71

Price / book · today's price, trailing year to Jul 31, 2026

EV / sales
14.9

EV / sales

Details›
Price / booktoday's price, trailing year to Jul 31, 2026
7.71
EV / EBIToperating margin −134%: the multiple describes the denominator
not meaningful
EV / salestoday's price, trailing year to Jul 31, 2026
14.9
Market capitalisation59.6 million shares, counted Sep 11, 2026
$1.71B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.